探索酸盐补充剂提高氧化的生物可用性和减少氧化应激:对高血压和内皮功能障碍在高血压的影响
Tatiana Palotta Minari1, Luciana Pellegrini Pisani1
1Department of Bioscience, Federal University of São Paulo (UNIFESP), Santos 11015-020, SP, Brazil.
European journal of pharmacology
|May 5, 2025
概括
酸盐补充剂可以通过提高氧化 (NO) 水平,减少氧化应激,降低高血压患者的血压来改善心血管健康. 这为传统治疗提供了潜在的替代方案.
科学领域:
- 心血管科学 心血管科学
- 营养生物化学 营养生物化学
背景情况:
- 高血压是一个全球性的健康问题,其特点是血压升高.
- 氧化 (NO) 由于其血管扩张特性,对内皮功能和心血管健康至关重要.
研究的目的:
- 审查酸盐补充剂在高血压管理中的潜力.
- 探索酸盐在增强氧化 (NO) 生物可用性和减少氧化应激方面的机制.
主要方法:
- 对酸盐及其对高血压的影响进行现有研究的全面分析.
- 对NO介导通路,内皮功能和氧化应激标志物的检查.
主要成果:
- 酸盐可以提高氧化 (NO) 水平,改善内皮功能,减少氧化应激.
- 酸有可能降低血压,减少对传统抗高血压药物的依赖.
结论:
- 酸作为高血压管理的成本有效策略具有前景.
- 建议的剂量范围 (6-12 mmol/day) 来自饮食来源,如绿叶蔬菜和甜菜汁.
- 需要进一步的研究来确认益处,优化剂量,并建立临床指导方针.
相关概念视频
Antihypertensive Drugs: Vasodilators
426
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
426
Nitric Oxide Signaling Pathway
4.8K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.8K
Antianginal Drugs: Nitrates and β-Blockers
443
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
443
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
383
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
383
Disorders of the Autonomic Nervous System
471
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
471
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
392
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
392


